ImmunoACT’s cell therapy to treat blood cancer gets CDSCO nod Subject :Science and Tech Section: Biotechnology Context: IIT Bombay-incubated Immunoadoptive Cell Therapy (ImmunoACT), in which drugmaker Laurus Labs holds about 34% stake, has received Central Drugs Standard Control Organisation’s (CDSCO) marketing authorisation approval of the ‘first’ humanised CD19-targeted Chimeric Antigen Receptor T cell […]